Evotec Raises EURO 30 m From Biotechnology Value Fund – GlobeNewswire (press release)
By Dr. Matthew Watson
Evotec Raises EURO 30 m From Biotechnology Value Fund GlobeNewswire (press release) HAMBURG, Germany, Aug. 31, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced a 9.9% increase of its share capital. Evotec resolved on a capital increase from its authorised capital against cash ... Evotec Raises EUR 30 Mln From Biotechnology Value Fund - Quick FactsRTT News EVOTEC AG : Evotec raises EUR 30 m from Biotechnology Value Fund4-traders (press release) |
Uncategorized
Comments Off on Evotec Raises EURO 30 m From Biotechnology Value Fund – GlobeNewswire (press release) |
September 1st, 2013
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research